One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Human Leukocyte Antigen (HLA) Targeted Therapy, Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2026" report has been added to ...

Australian-led research is unlocking new ways for immunotherapy to better target cancer. Cancer immunotherapy has ...

AURORA, Colo., Oct. 28, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking ...

Next, Hollenbach wanted to know how that particular kind of HLA molecule might be preventing a person from getting symptoms. It turns out that HLA-B*15:01 recognizes pieces of other kind of SARS ...

Association of mannitol (MAN) with cisplatin (CIS)-induced nephrotoxicity (NTX) and cumulative CIS dose (CCD). This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does ...

To allow the body to engage with foreign invaders, the immune cells recognize proteins which activate an immune response. These proteins are known as ‘antigens’ and are presented to immune cells that ...

Scholars from HSE University and the RAS Institute of Bioorganic Chemistry have demonstrated the efficiency of T-cell immune response against the Omicron variant of SARS-CoV-2. In approximately 90% of ...

(MENAFN- GlobeNewsWire - Nasdaq) The market for Human Leukocyte Antigen (HLA) targeted therapies is expanding, with the first therapy approval expected by 2030. Key opportunities include developing ...